CellMax Life logo

CellMax Life

Liquid biopsy company focused on cancer screening with a proprietary platform for detecting precancer and cancer cells

25 employees · est. 2013 · Sunnyvale, United States

VS
IV Diagnostics logo

IV Diagnostics

Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis and Disease Management

est. 2012

IV Diagnostics is the older company (2013 vs 2012).

Side-by-Side Comparison

CellMax Life IV Diagnostics
Founded
2013 2012 older
Headquarters
Sunnyvale, United States Not tracked yet
Employees
25 Not tracked yet
Industry
Biotechnology, Health Care Biotechnology, Health Care, Platforms
Funding Stage
Unknown Private Equity
Total Funding
$14.00M $1.19M
Funding Rounds
3 3
Services
development of non-invasive blood tests for cancer detection, colorectal cancer screening and prevention, adenoma detection technology Not tracked yet
Target Customers
individuals recommended for routine cancer screening, healthcare providers offering cancer prevention services Not tracked yet
Taxonomy
Liquid Biopsy, Cancer Screening, Precision Medicine, Early Cancer Detection, Non-invasive Tests, Circulating Tumor Cell, Next Generation Sequencing, DNA, CtDNA, Cancer Diagnostics, Proprietary Platform, Medical Innovation Cancer Detection, Circulating Tumor Cells, Early Detection, Prognosis, Disease Management, Metastatic Diseases, Cancer Stem Cells, Tumorigenic, Metastasis, Recurrence, Diagnostic Targets, Bloodstream, Primary Tumors, Quantifying CTCs, Characterization Of CTCs
Website
cellmaxlife.com ivdiagnostics.com
CellMax Life logo

About CellMax Life

CellMax Life, founded in 2013, is positioned at the forefront of the biotechnology and health care industries with its innovative focus on liquid biopsy technology for cancer screening. Their proprietary platform is tailored to detect pre-cancer and cancer cells, disrupting traditional diagnostic pa...

IV Diagnostics logo

About IV Diagnostics

IV Diagnostics, founded in 2012 , is a biotechnology startup focused on advancing early cancer detection using circulating tumor cells (CTCs) for improved prognosis and disease management. The company's slogan, "Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis an...

We will tell you when either one moves

BounceWatch watches CellMax Life and IV Diagnostics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CellMax Life and IV Diagnostics — by email.

Frequently Asked Questions

CellMax Life — Liquid biopsy company focused on cancer screening with a proprietary platform for detecting precancer and cancer cells. IV Diagnostics — Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis and Disease Management. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CellMax Life has raised $14.00M while IV Diagnostics has raised $1.19M.
CellMax Life and IV Diagnostics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CellMax Life with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CellMax Life on 12 Sep 2024, and IV Diagnostics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy